Cargando…

Oncogene-targeting nanoprobes for early imaging detection of tumor

Malignant tumors have been one of the major reasons for deaths worldwide. Timely and accurate diagnosis as well as effective intervention of tumors play an essential role in the survival of patients. Genomic instability is the important foundation and feature of cancer, hence, in vivo oncogene imagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenyue, Zhang, Peisen, Liu, Chuang, Xu, Yuping, Gan, Zhihua, Kang, Lei, Hou, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283312/
https://www.ncbi.nlm.nih.gov/pubmed/37340418
http://dx.doi.org/10.1186/s12951-023-01943-x
_version_ 1785061285755355136
author Li, Wenyue
Zhang, Peisen
Liu, Chuang
Xu, Yuping
Gan, Zhihua
Kang, Lei
Hou, Yi
author_facet Li, Wenyue
Zhang, Peisen
Liu, Chuang
Xu, Yuping
Gan, Zhihua
Kang, Lei
Hou, Yi
author_sort Li, Wenyue
collection PubMed
description Malignant tumors have been one of the major reasons for deaths worldwide. Timely and accurate diagnosis as well as effective intervention of tumors play an essential role in the survival of patients. Genomic instability is the important foundation and feature of cancer, hence, in vivo oncogene imaging based on novel probes provides a valuable tool for the diagnosis of cancer at early-stage. However, the in vivo oncogene imaging is confronted with great challenge, due to the extremely low copies of oncogene in tumor cells. By combining with various novel activatable probes, the molecular imaging technologies provide a feasible approach to visualize oncogene in situ, and realize accurate treatment of tumor. This review aims to declare the design of nanoprobes responded to tumor associated DNA or RNA, and summarize their applications in detection and bioimaging for tumors. The significant challenges and prospective of oncogene-targeting nanoprobes towards tumors diagnosis are revealed as well.
format Online
Article
Text
id pubmed-10283312
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102833122023-06-22 Oncogene-targeting nanoprobes for early imaging detection of tumor Li, Wenyue Zhang, Peisen Liu, Chuang Xu, Yuping Gan, Zhihua Kang, Lei Hou, Yi J Nanobiotechnology Review Malignant tumors have been one of the major reasons for deaths worldwide. Timely and accurate diagnosis as well as effective intervention of tumors play an essential role in the survival of patients. Genomic instability is the important foundation and feature of cancer, hence, in vivo oncogene imaging based on novel probes provides a valuable tool for the diagnosis of cancer at early-stage. However, the in vivo oncogene imaging is confronted with great challenge, due to the extremely low copies of oncogene in tumor cells. By combining with various novel activatable probes, the molecular imaging technologies provide a feasible approach to visualize oncogene in situ, and realize accurate treatment of tumor. This review aims to declare the design of nanoprobes responded to tumor associated DNA or RNA, and summarize their applications in detection and bioimaging for tumors. The significant challenges and prospective of oncogene-targeting nanoprobes towards tumors diagnosis are revealed as well. BioMed Central 2023-06-21 /pmc/articles/PMC10283312/ /pubmed/37340418 http://dx.doi.org/10.1186/s12951-023-01943-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Li, Wenyue
Zhang, Peisen
Liu, Chuang
Xu, Yuping
Gan, Zhihua
Kang, Lei
Hou, Yi
Oncogene-targeting nanoprobes for early imaging detection of tumor
title Oncogene-targeting nanoprobes for early imaging detection of tumor
title_full Oncogene-targeting nanoprobes for early imaging detection of tumor
title_fullStr Oncogene-targeting nanoprobes for early imaging detection of tumor
title_full_unstemmed Oncogene-targeting nanoprobes for early imaging detection of tumor
title_short Oncogene-targeting nanoprobes for early imaging detection of tumor
title_sort oncogene-targeting nanoprobes for early imaging detection of tumor
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283312/
https://www.ncbi.nlm.nih.gov/pubmed/37340418
http://dx.doi.org/10.1186/s12951-023-01943-x
work_keys_str_mv AT liwenyue oncogenetargetingnanoprobesforearlyimagingdetectionoftumor
AT zhangpeisen oncogenetargetingnanoprobesforearlyimagingdetectionoftumor
AT liuchuang oncogenetargetingnanoprobesforearlyimagingdetectionoftumor
AT xuyuping oncogenetargetingnanoprobesforearlyimagingdetectionoftumor
AT ganzhihua oncogenetargetingnanoprobesforearlyimagingdetectionoftumor
AT kanglei oncogenetargetingnanoprobesforearlyimagingdetectionoftumor
AT houyi oncogenetargetingnanoprobesforearlyimagingdetectionoftumor